Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence
- PMID: 3016306
- PMCID: PMC253097
- DOI: 10.1128/JVI.59.2.463-471.1986
Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence
Abstract
Strains of the murine coronavirus mouse hepatitis virus type 4 (MHV-4) which contained a mutation in the E2 peplomer glycoprotein were obtained by selection for resistance to neutralization by monoclonal antibodies. Characterization of six variants representing two independent epitopes on E2, E2B and E2C, by in vitro neutralization and antibody-binding assays demonstrated that selection for an alteration in epitope E2B also resulted in changes in epitope E2C and vice versa. We observed a mutation frequency of approximately 10(-4.3) to 10(-4.6), which is consistent with the expected occurrence of single point mutations. The variant virus strains were attenuated with respect to neurovirulence when compared with wild-type MHV-4. Mice normally develop encephalomyelitis and die after wild-type MHV-4 infection. Mice receiving 2- to 3-log-higher doses of the variant strains survived and developed demyelinating disease. As the disease progressed, evidence of remyelination and ongoing demyelination was observed up to 65 days after infection. Virus reisolated 15 days after infection retained the variant phenotype. The data indicate that the E2 glycoprotein plays a central role in determining the cellular tropism and virulence of MHV-4 in the mouse.
Similar articles
-
The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.J Gen Virol. 1988 Jan;69 ( Pt 1):87-98. doi: 10.1099/0022-1317-69-1-87. J Gen Virol. 1988. PMID: 2447229
-
Antigenic variation among murine coronaviruses: evidence for polymorphism on the peplomer glycoprotein, E2.Virus Res. 1985 Jun;2(4):317-28. doi: 10.1016/0168-1702(85)90028-0. Virus Res. 1985. PMID: 2412363 Free PMC article.
-
Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease.Virology. 1989 Mar;169(1):127-36. doi: 10.1016/0042-6822(89)90048-2. Virology. 1989. PMID: 2538027 Free PMC article.
-
The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation.Lab Anim Sci. 1986 Apr;36(2):130-5. Lab Anim Sci. 1986. PMID: 3009966
-
Pathogenesis of mouse hepatitis virus-induced demyelination.J Neurovirol. 1996 Dec;2(6):361-76. doi: 10.3109/13550289609146902. J Neurovirol. 1996. PMID: 8972418 Review.
Cited by
-
Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein.Virus Res. 1991 Mar;18(2-3):99-107. doi: 10.1016/0168-1702(91)90011-j. Virus Res. 1991. PMID: 1645909 Free PMC article.
-
The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system.Virology. 1992 Mar;187(1):178-88. doi: 10.1016/0042-6822(92)90306-a. Virology. 1992. PMID: 1310555 Free PMC article.
-
Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.Virology. 1987 Dec;161(2):429-37. doi: 10.1016/0042-6822(87)90136-x. Virology. 1987. PMID: 2825415 Free PMC article.
-
Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site.Virology. 1987 Dec;161(2):479-87. doi: 10.1016/0042-6822(87)90142-5. Virology. 1987. PMID: 2825419 Free PMC article.
-
Coronavirus-induced CNS disease: a model for virus-induced demyelination.J Neuroimmunol. 1988 Dec;20(2-3):111-6. doi: 10.1016/0165-5728(88)90141-5. J Neuroimmunol. 1988. PMID: 2848860 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials